Tirzepatide use is associated with a lower risk for CPAP use, hospitalization, and mortality in adults with obesity, T2D, and OSA.

Online CPAP shopping offers more models, better filtering, and faster comparisons than most showrooms can provide. Prices are often lower because online sellers have less overhead and can run bundles ...

Amid dwindling industry-specific volatilities, these five low-leverage stocks stand out as safer bets for investors seeking ...

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a leading medical technology company specializing in innovative respiratory products for homecare use, today announced the launch of ...

Circle Chart (formerly known as Gaon Chart) has revealed its chart rankings for the week of December 21 to 27! CORTIS topped this week’s physical album chart with their debut EP “COLOR OUTSIDE THE ...

“Stranger Things” star Joe Keery overtook Taylor Swift’s No. 1 spot on the Spotify charts over the weekend. Keery, who releases music under the alias DJO, got a boost on the Spotify rankings thanks to ...

If you read a book in 2025—just one book—you belong to an endangered species. Like honeybees and red wolves, the population of American readers, Lector americanus, has been declining for decades. The ...

For investors worldwide, 2025 was anything but boring. President Donald Trump’s return to the Oval Office shook up global markets. His aggressive tariff agenda quickly became one of the most ...

What happened in 2025? Well, a lot. There were tariffs, breakthroughs and disappointments with AI, and a wobbly economy that sent decidedly mixed signals. There were crises of purpose, execution, and ...

Ohio State’s depth chart isn’t likely to change drastically from the regular season to the College Football Playoff, but there could be a few tweaks as the Buckeyes enter the win-or-go-home portion of ...

There are some technical signs that on the surface suggest chip-sector bulls may be running out of steam and that it wouldn’t take much for bears to take control of the trend. But, looking a little ...

Incretin receptor agonists, such as tirzepatide, have shown promising effects in reducing the severity of obstructive sleep apnea in recent randomized clinical trials, but real-world evidence on their ...